InnoCare Optoelectronics (6861) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
10 Jun, 2026Executive summary
Consolidated financial statements received an unmodified audit opinion, confirming fair presentation in accordance with IFRS and local regulations.
The Group operates as a single segment focused on X-ray flat panel detectors, with significant revenue growth and global customer base.
Major customers each contributed over 10% of annual revenue, highlighting customer concentration.
Financial highlights
Operating revenue for 2025 was NT$2,293,791 thousand, up 15% year-over-year from NT$1,989,666 thousand.
Net income for 2025 reached NT$159,510 thousand, a 4% increase from NT$152,939 thousand in 2024.
Gross profit margin was 26% in 2025, slightly down from 28% in 2024.
Basic EPS for 2025 was NT$3.84, up from NT$3.79 in 2024.
Cash and cash equivalents increased to NT$869,065 thousand at year-end 2025.
Outlook and guidance
The Group expects continued application of new IFRS standards, with no material impact anticipated.
Planned relocation to a new plant and new lease agreement with the parent company starting March 2026.
Latest events from InnoCare Optoelectronics
- Q2 2024 saw double-digit revenue and profit growth, improved margins, and a cash dividend payout.6861
Q2 202410 Jun 2026 - Q3 2023 revenue rose 19% YoY to NT$483.7M, with net income of NT$30.9M and EPS of NT$0.75.6861
Q3 202410 Jun 2026 - Revenue and net income rose sharply year-over-year, with improved margins and strong cash flow.6861
Q4 202410 Jun 2026 - Q1 2024 saw 17% revenue growth and doubled net income, with EPS up to NT$1.03.6861
Q1 202510 Jun 2026 - Revenue up 12% year-over-year, net income at NT$74.9M, gross margin steady at 28%.6861
Q2 202510 Jun 2026 - Revenue up 13% year-over-year, but net income down 7% as margins narrowed.6861
Q3 202510 Jun 2026